Q1 2023 Agile Therapeutics Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Agile Therapeutics First Quarter 2023 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Matt Riley, Head of Investor Relations.
Hello, everyone, and welcome to today's conference call to discuss our first quarter 2023 financial results and corporate update.
Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook and financing prospects for the future; our outlook for the first half and full year of 2023; management's expectations for our future financial and operational performance, including our expectations regarding the market growth of Twirla and our operating expenses; our business strategy, our partnership with Afaxys and its ability to promote
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |